In a subset of patients with COPD, the interferon-gamma (IFN-γ) signature, harbouring a Th-1 response, has been shown to positively predict the response to anti-PD-1 treatments [84], with a rising count of CD8+ and CD4+ cells in these patients. This evidence concerns the gene CD8A and chronic obstructive pulmonary disease.